These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 19556867)

  • 1. An absence of stromal caveolin-1 is associated with advanced prostate cancer, metastatic disease and epithelial Akt activation.
    Di Vizio D; Morello M; Sotgia F; Pestell RG; Freeman MR; Lisanti MP
    Cell Cycle; 2009 Aug; 8(15):2420-4. PubMed ID: 19556867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progression.
    Ayala G; Morello M; Frolov A; You S; Li R; Rosati F; Bartolucci G; Danza G; Adam RM; Thompson TC; Lisanti MP; Freeman MR; Vizio DD
    J Pathol; 2013 Sep; 231(1):77-87. PubMed ID: 23729330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of secreted caveolin-1 in mouse models of prostate cancer progression.
    Watanabe M; Yang G; Cao G; Tahir SA; Naruishi K; Tabata K; Fattah EA; Rajagopalan K; Timme TL; Park S; Kurosaka S; Edamura K; Tanimoto R; Demayo FJ; Goltsov AA; Thompson TC
    Mol Cancer Res; 2009 Sep; 7(9):1446-55. PubMed ID: 19737975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of epithelial/stromal caveolin-1 expression in prostatic hyperplasia, high grade prostatic intraepithelial hyperplasia and prostatic carcinoma and its correlation with microvessel density.
    Mohammed DA; Helal DS
    J Egypt Natl Canc Inst; 2017 Mar; 29(1):25-31. PubMed ID: 28259631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of stromal caveolin-1 expression predicts poor clinical outcome in triple negative and basal-like breast cancers.
    Witkiewicz AK; Dasgupta A; Sammons S; Er O; Potoczek MB; Guiles F; Sotgia F; Brody JR; Mitchell EP; Lisanti MP
    Cancer Biol Ther; 2010 Jul; 10(2):135-43. PubMed ID: 20431349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caveolin-1 upregulation contributes to c-Myc-induced high-grade prostatic intraepithelial neoplasia and prostate cancer.
    Yang G; Goltsov AA; Ren C; Kurosaka S; Edamura K; Logothetis R; DeMayo FJ; Troncoso P; Blando J; DiGiovanni J; Thompson TC
    Mol Cancer Res; 2012 Feb; 10(2):218-29. PubMed ID: 22144662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of stromal caveolin-1 expression in malignant melanoma metastases predicts poor survival.
    Wu KN; Queenan M; Brody JR; Potoczek M; Sotgia F; Lisanti MP; Witkiewicz AK
    Cell Cycle; 2011 Dec; 10(24):4250-5. PubMed ID: 22134245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utilizing digital pathology to quantify stromal caveolin-1 expression in malignant and benign ovarian tumors: Associations with clinicopathological parameters and clinical outcomes.
    Saeed-Vafa D; Marchion DC; McCarthy SM; Hakam A; Lopez A; Wenham RM; Apte SM; Chen DT; Magliocco AM; Lancaster JM; Reid BM; Permuth JB
    PLoS One; 2021; 16(11):e0256615. PubMed ID: 34813586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: genetic ablation of Cav-1 delays advanced prostate tumor development in tramp mice.
    Williams TM; Hassan GS; Li J; Cohen AW; Medina F; Frank PG; Pestell RG; Di Vizio D; Loda M; Lisanti MP
    J Biol Chem; 2005 Jul; 280(26):25134-45. PubMed ID: 15802273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down-regulation of stromal caveolin-1 expression in esophageal squamous cell carcinoma: a potent predictor of lymph node metastases, early tumor recurrence, and poor prognosis.
    Jia Y; Wang N; Wang J; Tian H; Ma W; Wang K; Tan B; Zhang G; Yang S; Bai B; Cheng Y
    Ann Surg Oncol; 2014 Jan; 21(1):329-36. PubMed ID: 23982252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
    Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
    Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stromal caveolin-1 expression in breast carcinoma. Correlation with early tumor recurrence and clinical outcome.
    El-Gendi SM; Mostafa MF; El-Gendi AM
    Pathol Oncol Res; 2012 Apr; 18(2):459-69. PubMed ID: 22057638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of caveolin-1 in prostate cancer: clinical implications.
    Thompson TC; Tahir SA; Li L; Watanabe M; Naruishi K; Yang G; Kadmon D; Logothetis CJ; Troncoso P; Ren C; Goltsov A; Park S
    Prostate Cancer Prostatic Dis; 2010 Mar; 13(1):6-11. PubMed ID: 19581923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Towards a new "stromal-based" classification system for human breast cancer prognosis and therapy.
    Witkiewicz AK; Casimiro MC; Dasgupta A; Mercier I; Wang C; Bonuccelli G; Jasmin JF; Frank PG; Pestell RG; Kleer CG; Sotgia F; Lisanti MP
    Cell Cycle; 2009 Jun; 8(11):1654-8. PubMed ID: 19448435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caveolin-1 interacts with a lipid raft-associated population of fatty acid synthase.
    Di Vizio D; Adam RM; Kim J; Kim R; Sotgia F; Williams T; Demichelis F; Solomon KR; Loda M; Rubin MA; Lisanti MP; Freeman MR
    Cell Cycle; 2008 Jul; 7(14):2257-67. PubMed ID: 18635971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caveolin-1 is required for the upregulation of fatty acid synthase (FASN), a tumor promoter, during prostate cancer progression.
    Di Vizio D; Sotgia F; Williams TM; Hassan GS; Capozza F; Frank PG; Pestell RG; Loda M; Freeman MR; Lisanti MP
    Cancer Biol Ther; 2007 Aug; 6(8):1263-8. PubMed ID: 17786030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Caveolin-1 mediates testosterone-stimulated survival/clonal growth and promotes metastatic activities in prostate cancer cells.
    Li L; Yang G; Ebara S; Satoh T; Nasu Y; Timme TL; Ren C; Wang J; Tahir SA; Thompson TC
    Cancer Res; 2001 Jun; 61(11):4386-92. PubMed ID: 11389065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caveolin-1 regulates VEGF-stimulated angiogenic activities in prostate cancer and endothelial cells.
    Tahir SA; Park S; Thompson TC
    Cancer Biol Ther; 2009 Dec; 8(23):2286-96. PubMed ID: 19923922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Caveolin-1 Expression in Tumor Stroma Is Associated with a Favourable Outcome in Prostate Cancer Patients Managed by Watchful Waiting.
    Hammarsten P; Dahl Scherdin T; Hägglöf C; Andersson P; Wikström P; Stattin P; Egevad L; Granfors T; Bergh A
    PLoS One; 2016; 11(10):e0164016. PubMed ID: 27764093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MYC Drives Pten/Trp53-Deficient Proliferation and Metastasis due to IL6 Secretion and AKT Suppression via PHLPP2.
    Nowak DG; Cho H; Herzka T; Watrud K; DeMarco DV; Wang VM; Senturk S; Fellmann C; Ding D; Beinortas T; Kleinman D; Chen M; Sordella R; Wilkinson JE; Castillo-Martin M; Cordon-Cardo C; Robinson BD; Trotman LC
    Cancer Discov; 2015 Jun; 5(6):636-51. PubMed ID: 25829425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.